Guidance Document on the Distribution of Drugs as Samples - Summary

The purpose of this document is to assist stakeholders with the interpretation of legislation and regulatory requirements about distributing samples of prescription drugs, non-prescription drugs and natural health products.

Data and Resources

Additional Info

Field Value
Last Updated April 17, 2026, 21:52 (UTC)
Created April 17, 2026, 21:52 (UTC)
criticality_level []
geographic_scope []
open_canada_collection publication
open_canada_date_published 2020-04-27 00:00:00
open_canada_keywords {"fr": ["Document d'orientation", "distribution de médicaments sous forme d'échantillons", "distribution d'échantillons", "médicaments sur ordonnance", "médicaments sans ordonnance", "produits de santé naturels", "intervenants", "interprétation des lois et règlements"], "en": ["Guidance document", "distribution of drugs as samples", "distributing samples", "prescription drugs", "non-prescription drugs", "natural health products", "stakeholders", "interpretation of legislation and regulatory"]}
open_canada_subject ["health_and_safety"]
sensitivity_level unrestricted
title_fr Ligne directrice sur la distribution de médicaments sous forme d’échantillons - Sommaire
update_frequency as_needed